awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36166433-08BF6C6B-7C8A-4410-A459-EE9111E71484
Q36166433-08BF6C6B-7C8A-4410-A459-EE9111E71484
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166433-08BF6C6B-7C8A-4410-A459-EE9111E71484
Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.
P2860
Q36166433-08BF6C6B-7C8A-4410-A459-EE9111E71484
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166433-08BF6C6B-7C8A-4410-A459-EE9111E71484
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0baaf4ba81bed172877d03972da530e000343e1f
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.